Case Background
Heart rescue operation
· V-Clamp ❤ Case sharing·
Before the festival, we received a case from Nanjing, named yoyo, a 12-year-old male dog, weighing 2.3kg. It was diagnosed as valve degenerative disease, mmvnd B2, with mild tricuspid regurgitation. Two dimensional left ventricular and left atrial dilation and mitral valve thickening were seen.
On February 28, 2021 Beijing time, Shanghai Hongyu medical and Nanjing Abel Medical Center launched interventional treatment of mitral regurgitation for yoyo.
Preoperative MR4 +, three bundle central reflux. After clamping A2P2 region, MR1 + and mitral regurgitation were significantly improved immediately.
Yoyo before operation
Clinical Presentation
I'm yoyo. Although I'm 12 years old, I think I'm still young~
Recently, I suddenly don't like to move. Careful baby, my master took me to see the doctor. He said I had a heart attack... Whining
Procedure & Outcome
Preoperative
After operation
Thank the doctors who helped me
SPRING
Follow-up & Insights
I'm still a little confused after the operation
On the third day after the operation, I was in high spirits and took a picture of my handsome head~
"Come on, Lolo, I'm leaving the hospital ~ ~"
Discussion
·Backflow knowledge·
Mitral regurgitation is very common in small dogs in the elderly, with an incidence rate of 20-30%. In the United States alone, there are about 7.18 million mitral regurgitation dogs. The occurrence of the disease is related to breed, age and gender. The age of sick dogs is mostly distributed in 5 ~ l 6 years old. The disease rate increases with age, mostly in small dogs and male dogs.
Canine mitral regurgitation has characteristic night cough, night asthma, weakness, exercise intolerance or fatigue after exercise and excitement, prolonged recovery time, severe purple tongue color, syncope and so on. The survival time of dogs with severe mitral regurgitation disease is only 3-6 months.
The control effect of traditional drugs is general, which can only alleviate symptoms, can not be cured, and the condition will still gradually worsen. The monthly drug cost ranges from 2000 to 4000 yuan. Or valve replacement. The operation is difficult, high risk, high mortality and expensive. At present, only a few teams in the world have completed individual cases, which can not be popularized in a large area.
Shanghai Hongyu medical v-clamp minimally invasive surgery has the advantages of high safety, small trauma and fast recovery. It does not need cardiac arrest and cardiopulmonary bypass. It cuts a 2-3cm incision in the precordial area, punctures the heart and sends instruments to complete mitral valve repair, reduces mitral regurgitation, and provides a new technical scheme for the treatment of canine mitral regurgitation.
· HONGYU·
Scan and add attention
